Dietary sodium and risk of stroke in the Northern Manhattan study
- PMID: 22499576
- PMCID: PMC3347890
- DOI: 10.1161/STROKEAHA.111.641043
Dietary sodium and risk of stroke in the Northern Manhattan study
Abstract
Background and purpose: The American Heart Association recommends limiting sodium intake to ≤ 1500 mg/day for ideal cardiovascular health. Although sodium intake has been linked to vascular disease by direct relationship with hypertension, few studies have supported an association with stroke risk.
Methods: Participants were from the Northern Manhattan Study (mean age 69 ± 10 years, 64% women, 21% white, 53% Hispanic, 24% black), a population-based cohort study of stroke incidence. Sodium intake was assessed with a food frequency questionnaire at baseline and evaluated continuously and categorically: ≤ 1500 mg/day (12%), 1501 to 2300 mg/day (24%), 2301 to 3999 mg/day (43%), and ≥ 4000 mg/day (21%). Over a mean follow-up of 10 years, we examined the association between sodium consumption and 235 strokes using Cox models adjusting for sociodemographics, diet, behavioral/lifestyle, and vascular risk factors.
Results: Of 2657 participants with dietary data, the mean sodium intake was 3031 ± 1470 mg/day (median, 2787; interquartile range, 1966-3815 mg/day). Participants who consumed ≥ 4000 mg/day sodium had an increased risk of stroke (hazard ratio, 2.59; 95% CI, 1.27-5.28) versus those who consumed ≤ 1500 mg/day with a 17% increased risk of stroke for each 500-mg/day increase (95% CI, 1.07-1.27).
Conclusions: High sodium intake was prevalent and associated with an increased risk of stroke independent of vascular risk factors. The new American Heart Association dietary sodium goals will help reduce stroke risk.
Conflict of interest statement
Disclosures: We have no conflicts of interest, financial or otherwise, to disclose.
Comment in
-
Less salt and less risk of stroke: further support to action.Stroke. 2012 May;43(5):1195-6. doi: 10.1161/STROKEAHA.112.650101. Epub 2012 Apr 12. Stroke. 2012. PMID: 22499577 No abstract available.
References
-
- Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: A call to action from the american heart association. Circulation. 2011;123:1138–1143. - PubMed
-
- Stokes J, 3rd, Kannel WB, Wolf PA, D’Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The framingham study--30 years of follow-up. Hypertension. 1989;13:I13–18. - PubMed
-
- Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerova J, Richart T, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA : the journal of the American Medical Association. 2011;305:1777–1785. - PubMed
-
- Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, et al. Stroke incidence among white, black, and hispanic residents of an urban community: The northern manhattan stroke study. Am J Epidemiol. 1998;147:259–268. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
